Clinical Trial Update: Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing two reduced-intensity conditioning regimens—clofarabine vs. fludarabine—in adults with acute myeloid leukemia in remission who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clolar (Clofarabine)
• Fludara (fludarabine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Acute Myeloid Leukemia in Remission | Phase 2 | Status: RECRUITING